Funds holding REVIVA PHARMACEUTICALS HOLDINGS INC
5 funds declare a position · 0 ETFs and 5 other funds · 198.7K $· 144.8K € · US76152G1004
Each line carries its report date.
| Fund | Shares | Value | Weight | |
|---|---|---|---|---|
| ABANTE QUANT VALUE, F.I. ABANTE ASESORES GESTION, SGIIC, S.A. | 144.8K € | 0.77 % | as of Dec 31, 2025 · Original filing | |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 548,463 | 117.8K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 216,722 | 46.5K $ | as of Feb 28, 2026 · Original filing | |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 140,338 | 30.1K $ | as of Feb 28, 2026 · Original filing | |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 19,951 | 4.3K $ | as of Feb 28, 2026 · Original filing |
Institutional managers
1 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| IFP Advisors, Inc | 4,000 | 714 $ | as of Mar 31, 2026 |